Genesis Healthcare, Inc. is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities. Its services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Residential & Long Term Care
- Sub-Industry: Health Care Facilities
- Symbol: NYSE:SKH
- CUSIP: 83066R10
- Web: www.genesishcc.com
- Trailing P/E Ratio: N/A
- P/E Growth: N/A
- Net Margins: -7.87%
- Return on Assets: -7.55%
Frequently Asked Questions for Genesis Healthcare (NYSE:SKH)
What is Genesis Healthcare's stock symbol?
Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "SKH."
How were Genesis Healthcare's earnings last quarter?
Genesis Healthcare Inc (NYSE:SKH) posted its quarterly earnings data on Monday, November, 3rd. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.07 by $0.06. The firm had revenue of $208.60 million for the quarter, compared to the consensus estimate of $208.10 million. The company's revenue was up .0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.06 EPS. View Genesis Healthcare's Earnings History.
Who are some of Genesis Healthcare's key competitors?
Some companies that are related to Genesis Healthcare include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Stryker (SYK), Becton Dickinson and Co (BDX), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), VCA (WOOF), Valeant Pharmaceuticals Intl (VRX), NMC Health PLC (NMC), ConvaTec Group PLC (CTEC), Health Net (HNT), Catalent (CTLT), Patheon NV (PTHN), Mediclinic International PLC (MDC) and Puma Biotechnology (PBYI).
Who are Genesis Healthcare's key executives?
Genesis Healthcare's management team includes the folowing people:
- Robert H. Fish, Chairman of the Board
- Paul David Bach, President, Executive Vice President
- George V. Hager Jr., Chief Executive Officer, Director
- Thomas DiVittorio, Chief Financial Officer, Treasurer, Assistant Secretary
- Daniel Allen Hirschfeld, President - Genesis Rehab Services
- Stephen Saville, President of Career Staff Unlimited
- Jeanne Phillips, Chief Human Resource Officer
- David C. Almquist, Executive Vice President, President West Division
- Richard P. Blinn, Executive Vice President, President Northeast Division
- Raymond L. Thivierge, Executive Vice President - West Division
How do I buy Genesis Healthcare stock?
Shares of Genesis Healthcare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Genesis Healthcare's stock price today?
MarketBeat Community Rating for Genesis Healthcare (NYSE SKH)MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Genesis Healthcare stock can currently be purchased for approximately $8.30.
Consensus Ratings for Genesis Healthcare (NYSE:SKH) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Genesis Healthcare (NYSE:SKH)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Genesis Healthcare (NYSE:SKH)Earnings History by Quarter for Genesis Healthcare (NYSE SKH)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/3/2014||Q314||$0.07||$0.13||$208.10 million||$208.60 million||View||Listen|
|8/11/2014||Q214||$0.06||$0.07||$209.15 million||$207.00 million||View||Listen|
|5/5/2014||Q114||$0.07||$0.06||$210.39 million||$207.30 million||View||Listen|
|2/11/2014||Q413||$0.10||$0.06||$215.35 million||$208.30 million||View||Listen|
|11/4/2013||Q313||$0.10||$0.06||$214.47 million||$212.40 million||View||N/A|
|8/5/2013||Q2 2013||$0.16||$0.09||$219.58 million||$213.70 million||View||N/A|
|5/6/2013||Q1 2013||$0.18||$0.10||$222.52 million||$218.90 million||View||N/A|
|2/11/2013||Q4 2012||$0.19||$0.16||$219.67 million||$219.20 million||View||N/A|
|11/5/2012||Q312||$0.20||$0.21||$218.92 million||$216.60 million||View||N/A|
Earnings Estimates for Genesis Healthcare (NYSE:SKH)
Current Year EPS Consensus Estimate: $0.00 EPS
Next Year EPS Consensus Estimate: $0.00 EPS
Dividend History for Genesis Healthcare (NYSE:SKH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Genesis Healthcare (NYSE:SKH)Insider Trades by Quarter for Genesis Healthcare (NYSE:SKH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/14/2013||Boyd Hendrickson||CEO||Sell||48,774||$5.02||$244,845.48|| |
|8/6/2013||Boyd W Hendrickson||CEO||Sell||4,983||$6.03||$30,047.49|| |
|8/5/2013||Boyd W Hendrickson||CEO||Sell||24,671||$6.49||$160,114.79|| |
|8/2/2013||Boyd W Hendrickson||CEO||Sell||45,346||$6.58||$298,376.68|| |
|7/2/2013||Boyd W Hendrickson||CEO||Sell||29,988||$6.46||$193,722.48|| |
|7/1/2013||Boyd W Hendrickson||CEO||Sell||28,112||$6.61||$185,820.32|| |
|11/1/2012||Boyd W Hendrickson||CEO||Sell||1,567||$8.00||$12,536.00|| |
Headline Trends for Genesis Healthcare (NYSE:SKH)
Latest Headlines for Genesis Healthcare (NYSE:SKH)
Genesis Healthcare (SKH) Chart for Saturday, September, 23, 2017